Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yi, Lina ^a,b,c   Sasaki, Yuka ^b   Nagai, Hideaki ^d   Ishikawa, Satoru ^e   Takamori, Mikio ^f   Sakashita, Kentaro ^c,f   Saito, Takefumi ^g   Fukushima, Kiyoyasu ^h   Igarashi, Yuriko ^a   Aono, Akio ^a   Chikamatsu, Kinuyo ^a   Yamada, Hiroyuki ^a   Takaki, Akiko ^a   Mori, Toru ^a   Mitarai, Satoshi ^a,c  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^b Japan Anti tuberculosis Association   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d TOKYO NATIONAL HOSPITAL   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION   (Japan)

^f TOKYO METROPOLITAN TAMA MEDICAL CENTER   (Japan)

^g Center of Chest Diseases and Severe Motor and Intellectual Disabilities   (Japan)

^h Japanese Red Cross Society   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; COMPARATIVE STUDY; EVALUATION STUDY; FEMALE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; JAPAN; MALE; MIDDLE AGED; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; YOUNG ADULT;

ADULT; AGED; FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; JAPAN; MALE; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; YOUNG ADULT;

EID: 84979943917     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30617     Document Type: Article

References (34)

1. World Health Organization. Global Tuberculosis Report 2015. (2015) Available at: http://www.who.int/tb/publications/global-report/en (Accessed: 20th June 2016).
2. World Health Organization. Tuberculosis Country Profiles. Available at: http://www.who.int/tb/country/data/profiles/en (Accessed: 20th June 2016).
3. Bothamley, G. H. IFN-gamma-release assays in the management of tuberculosis. Expert. Rev. Respir. Med. 1, 365-375 (2007).
4. Brodie, D. et al. Use of an interferon-gamma release assay to diagnose latent tuberculosis infection in foreign-born patients. Chest. 133, 869-874 (2008).
5. Centers for Disease Control and Prevention. Tuberculosis (TB) Available at: http://www.cdc.gov/tb/publications/factsheets/testing/igra.htm (Accessed: 20th June 2016).
6. Lewinsohn, D. M. et al. Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity. J. Immunol. 166, 439-446 (2001).
7. Andrews, J. R. et al. The dynamics of QuantiFERON-TB Gold In-Tube conversion and reversion in a cohort of South African adolescents. Am. J. Respir. Crit. Care. Med. 191, 584-591 (2015).
8. Dorman, S. E. et al. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the united states. Am. J. Respir. Crit. Care. Med. 189, 77-87 (2014).
9. Nikolova, M. et al. Antigen-specific CD4-And CD8-posfitive signatures in different phases of Mycobacterium tuberculosis infection. Diagn. Microbiol. Infect. Dis. 75, 277-281 (2013).
10. Grotzke, J. E. & Lewinsohn, D. M. Role of CD8+ T lymphocytes in control of Mycobacterium tuberculosis infection. Microbes. Infect. 7, 776-788 (2005).
11. Green, A. M., Difazio, R. & Flynn, J. L. IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. J. Immunol. 190, 270-277 (2013).
12. Jasenosky, L. D., Scriba, T. J., Hanekom, W. A. & Goldfeld, A. E. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol. Rev. 264, 74-87 (2015).
13. Cardoso, F. L. et al. T-Cell Responses to the Mycobacterium tuberculosis-Specific Antigen ESAT-6 in Brazilian Tuberculosis Patients. Infect. Immun. 70, 6707-6714 (2002).
14. Place, S. et al. Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans. Am. J. Respir. Crit. Care. Med. 182, 848-854 (2010).
15. Sargentini, V. et al. Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis. BMC. Infect. Dis. 9, 99 (2009).
16. Lucia, B. et al. First independent evaluation of QuantiFERON-TB Plus performace. Eur. Respir. J. in press: doi:10.1183/13993003.02033-3015 (2016).
17. Diel, R., Loddenkemper, R. & Nienhaus, A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: A metaanalysis. Chest. 137, 952-968 (2010).
18. Prevention Committee, Japanese Society of Tuberculosis: Guidelines for using QuantiFERONTB Gold In-Tube. Kekkaku. 88, 33-37 (2013).
19. Bossuyt, P. et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin. Chem. 49, 7-18 (2003).
20. Mori, T. Recent trends in tuberculosis, Japan. Emerg. Infect. Dis. 6, 566-568 (2000).
21. Aagaard, C. et al. Mapping Immune Reactivity toward Rv2653 and Rv2654: Two novel low-molecular-mass antigens found specifically in the Mycobacterium tuberculosis complex. J. Infect. Dis. 189, 812-819 (2004).
22. Brock, I. et al. Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J. Clin. Microbiol. 42, 2379-2387 (2004).
23. Harada, N. et al. Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M.Tuberculosis infection. J. Infect. 56, 348-353 (2008).
24. Serbina, N. V., Lazarevic, V. & Flynn, J. L. CD4 (+ ) T cells are required for the development of cytotoxic CD8 (+ ) T cells during Mycobacterium tuberculosis infection. J. Immunol. 167, 6991-7000 (2001).
25. Prezzemolo, T. et al. Functional signatures of human CD4 and CD8 T cell responses to Mycobacterium tuberculosis. Front. Immunol. 5, 180 (2014).
26. Nyendak, M. R. et al. Mycobacterium tuberculosis specific CD8 (+ ) T cells rapidly decline with antituberculosis treatment. PLoS. One. 8, e81564 (2013).
27. Tyler, D. B. & Joel, D. E. CD4+ T cell dependent IFN-γ production by CD8+ effector T cells in M.Tuberculosis infection. J. Immunol. 189, 2530-2536 (2012).
28. Sollai, S., Galli, L., de Martino, M. & Chiappini, E. Systematic review and meta-Analysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: A 2013 update. BMC. Infect. Dis. 14, Suppl 1, S6 (2014).
29. Santin, M., Munoz, L. & Rigau, D. Interferon-γ release assays for the diagnosis of tuberculosis and tuberculosis infection in HIVinfected adults: A systematic review and meta-Analysis. PLoS. One. 7, e32482 (2012).
30. Lancioni, C. et al. CD8+ T cells provide an immunologic signature of tuberculosis in young children. Am. J. Respir. Crit. Care. Med. 185, 206-12 (2012).
31. Fong, K. S. et al. Challenges of Interferon-γ Release Assay Conversions in Serial Testing of Health-care Workers in a TB Control Program. Chest. 142, 55-62 (2012).
32. Nikolova, M. et al. Antigen-specific CD4-And CD8-positive signatures in different phases of Mycobacterium tuberculosis infection. Diagn. Microbiol. Infect. Dis. 75, 277-81 (2013).
33. Ryan, A. A. et al. Antigen load governs the differial priming of CD8 T cells in response to the Bacille Calmette Guérin vaccine or Mycobacterium tuberculosis infection. J. Immunol. 182, 7172-7 (2009).
34. World Health Organization. WHO Strategic and Technical Advisory Group for Tuberculosis (STAG-TB). Report of the tenth meeting. Available at: http://www.who.int/tb/advisory-bodies/stag-Tb-report-2010 (Accessed: 20th June 2016).